Skip to main content
. 2022 Jun 9;65:1–7. doi: 10.1016/j.breast.2022.05.007

Table 1.

Characteristics of cases and matched controls after breast cancer therapy in 1998–2008.

Characteristics Cases
Controls
N = 494 100 (%c) N = 988 100 (%c)
Year of breast cancer diagnosis
 1998–2000 62 12.55 129 13.06
 2001–2003 94 19.03 182 18.42
 2004–2006 213 43.12 441 44.64
 2007–2008 125 25.30 236 23.89
Age at breast cancer diagnosis
 Mean 63.14 / 63.10 /
 SDa 11.93 / 11.85 /
Laterality
 Left 264 53.44 540 54.66
 Right 230 46.56 448 45.34
T-stage
 1 267 54.05 572 57.89
 2 151 30.57 307 31.07
 3 21 4.25 29 2.94
 4 26 5.26 40 4.05
 In situ 21 4.25 33 3.34
 Unknown 8 1.62 7 0.71
N-stage
 0 311 62.96 586 59.31
 1 111 22.47 248 25.10
 2 34 6.88 77 7.79
 3 15 3.04 45 4.55
 X 23 4.66 32 3.24
BMIb
 <25.0 207 41.90 411 41.60
 ≥25.0 253 51.21 509 51.52
 Unknown 34 6.88 68 6.88
History of cardiac diseased
 Yes 84 17.00 168 17.00
 No/unknown 410 83.00 820 83.00
Chemotherapy
 Yes 215 43.52 398 40.28
 No 276 55.87 576 58.30
 Unknown 3 0.61 14 1.42
Endocrine therapy
 Yes 382 77.33 745 75.40
 No 98 19.84 201 20.34
 Unknown 14 2.83 42 4.25
Type of surgery
 Nonee 3 0.61 1 0.10
 Breast conserving 425 86.23 843 85.32
 Mastectomy 66 13.36 144 14.57
 Unknown 0 0.00 0 0.00
a

SD: Standard deviation.

b

BMI: Body Mass Index.

c

Percentages may not add up to a total of 100 due to rounding.

d

History of cardiac disease at the time of breast cancer diagnosis, including history of cardiac infarction, coronary heart disease, angina pectoris, NYHA≥3, dysrhythmia, vitium cordis or use of a pacemaker.

e

Patients who did not receive breast conserving surgery or mastectomy during their breast cancer therapy.